ELV vs PGR
Elevance Health, Inc. and Progressive Corp/oh, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | ELV | PGR |
|---|---|---|
| Revenue | $199.1B | $87.7B |
| Net income | $5.7B | $11.3B |
| Gross margin | 89.4% | — |
| Net margin | 2.8% | 12.9% |
| Return on equity | 13.3% | 40.4% |
| Diluted EPS | $25.21 | $19.23 |
| Dividend / share | $5.92 | $13.90 |
| Payout ratio | 27.0% | 25.4% |
| Free cash flow | $3.2B | $17.2B |
| Equity | $43.9B | $30.3B |
| Net debt / equity | 0.51× | −0.00× |
| Current ratio | 1.54× | — |
| Revenue CAGR 5y | 10.3% | 15.5% |
| Profit CAGR 5y | 4.4% | 14.7% |
ELV bills 2.3× the revenue of PGR, and PGR keeps more of each dollar of revenue as profit (12.9% against 2.8%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | ELV | PGR |
|---|---|---|
| FY2025 | $199.1B | $87.7B |
| FY2024 | $177.0B | $75.4B |
| FY2023 | $171.3B | $62.1B |
| FY2022 | $156.6B | $49.6B |
| FY2021 | $138.6B | $47.7B |
| FY2020 | $121.9B | $42.7B |
| FY2019 | $104.2B | $39.0B |
| FY2018 | $92.1B | $32.0B |
| FY2017 | $90.0B | $26.8B |
| FY2016 | $84.9B | $23.4B |
Net income by year
Bottom line
| Fiscal year | ELV | PGR |
|---|---|---|
| FY2025 | $5.7B | $11.3B |
| FY2024 | $6.0B | $8.5B |
| FY2023 | $6.0B | $3.9B |
| FY2022 | $5.9B | $722.0M |
| FY2021 | $6.2B | $3.4B |
| FY2020 | $4.6B | $5.7B |
| FY2019 | $4.8B | $4.0B |
| FY2018 | $3.8B | $2.6B |
| FY2017 | $3.8B | $1.6B |
| FY2016 | $2.5B | $1.0B |
Advertisement
AdSense · Rectangle 336×280